← Leaderboards
Paola Massari
Tufts University Boston
$2,778,263
Attributed
$2,778,263
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $821.3K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,778,263 · 4
By mechanism
R01$1,680,515 · 1
R21$913,350 · 2
R03$184,398 · 1
Top collaborators
No co-investigators on record.
Most similar at Tufts University Boston
Same institution · by research overlap
- Martin S Obin$1,883,620
Others in their field
Top investigators on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Lawrence Corey · Fred Hutchinson Cancer Center$252,110,127
- Wafaa M. El-Sadr · Columbia University Health Sciences$232,152,340
- Myron S Cohen · Family Health International$208,921,087
- Barbara Driver · Westat, Inc.$190,429,693
- Judith S. Currier · University Of California Los Angeles$149,317,678
Research focus
WomanProductionSurfaceVaccinesInfertilityAntibodiesImmunoglobulin AStructureVaccine CandidateMouse ModelReportingSexually Transmitted DiseasesMaleImmunityAntigensAdjuvantAntibioticsInfectionImmunoglobulin GImmunizeResponseInterferon Type IiImmuneCytokine
Grant awards (9)
Novel vaccine antigens against N. gonorrhoeae$549,041
R01 · FY2025 · AI · contact PI
Novel vaccine antigens against N. gonorrhoeae$551,279
R01 · FY2023 · AI · contact PI
Novel vaccine antigens against N. gonorrhoeae$580,195
R01 · FY2022 · AI · contact PI
MOMP-based recombinant antigens for a Chlamydia vaccine$241,100
R21 · FY2022 · AI · contact PI
MOMP-based recombinant antigens for a Chlamydia vaccine$218,500
R21 · FY2021 · AI · contact PI
Gonococcal In-vivo Expressed Factors (IVEFs) as novel vaccine antigens against N. gonorrhoeae infection$247,500
R21 · FY2019 · AI · contact PI
Gonococcal In-vivo Expressed Factors (IVEFs) as novel vaccine antigens against N. gonorrhoeae infection$206,250
R21 · FY2018 · AI · contact PI
Novel Recombinant Chlamydia Antigens$84,097
R03 · FY2017 · AI · contact PI
Novel Recombinant Chlamydia Antigens$100,301
R03 · FY2016 · AI · contact PI